NFKB1 and arthritic joint disease: However, treatment of rats with established clinical signs of arthritis with TAK-242 at 5 mg/kg resulted in a highly significant reduction in mRNA expression levels of NF-κB-p65 and AP-1 when compared to arthritic rats and rats treated with TAK-242 at 3 mg/kg.